Aveanna Healthcare (NASDAQ:AVAH) Sets New 12-Month High – Here’s Why

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) hit a new 52-week high during trading on Friday . The company traded as high as $5.99 and last traded at $5.87, with a volume of 202219 shares changing hands. The stock had previously closed at $5.59.

Analysts Set New Price Targets

AVAH has been the topic of a number of research reports. UBS Group upped their price objective on Aveanna Healthcare from $1.70 to $2.80 and gave the company a “sell” rating in a report on Friday, August 9th. Royal Bank of Canada upped their price objective on Aveanna Healthcare from $3.00 to $5.00 and gave the company a “sector perform” rating in a report on Friday, August 9th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on Aveanna Healthcare from $3.00 to $5.00 and gave the company a “buy” rating in a research report on Friday, August 9th.

Aveanna Healthcare Trading Up 4.3 %

The business has a 50-day moving average price of $5.13 and a two-hundred day moving average price of $3.90. The stock has a market capitalization of $1.13 billion, a P/E ratio of -8.95 and a beta of 2.13.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings data on Thursday, August 8th. The company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.03. The business had revenue of $504.96 million for the quarter, compared to the consensus estimate of $494.02 million. On average, sell-side analysts forecast that Aveanna Healthcare Holdings Inc. will post -0.09 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Aveanna Healthcare

Large investors have recently bought and sold shares of the company. SG Americas Securities LLC purchased a new stake in Aveanna Healthcare in the 3rd quarter valued at about $101,000. Acadian Asset Management LLC lifted its holdings in Aveanna Healthcare by 185.6% during the first quarter. Acadian Asset Management LLC now owns 29,385 shares of the company’s stock worth $72,000 after acquiring an additional 19,096 shares during the period. Mackenzie Financial Corp boosted its position in Aveanna Healthcare by 35.9% in the second quarter. Mackenzie Financial Corp now owns 45,674 shares of the company’s stock worth $126,000 after purchasing an additional 12,075 shares during the last quarter. Creative Planning grew its stake in Aveanna Healthcare by 21.3% in the 3rd quarter. Creative Planning now owns 48,502 shares of the company’s stock valued at $252,000 after purchasing an additional 8,502 shares during the period. Finally, Bank of New York Mellon Corp increased its position in shares of Aveanna Healthcare by 6.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 149,761 shares of the company’s stock valued at $413,000 after purchasing an additional 9,243 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.